In this brief monologue, Matt Kelly reflects on the evolution of integrative oncology over the past 25+ years. He contrasts the earlier mindset of searching for a single "silver bullet" that could corner cancer and boost the immune system with the more recent, and now prevailing, approach of therapeutic synergy—combining multiple modalities to enhance each other's effects. Kelly notes that about a decade ago the field began truly integrating therapies, and he predicts that the future will involve ever‑greater synergy, which clinicians are already observing as leading to stronger, more durable cancer responses. Key points: - Historical focus on a single, dominant therapy (25+ years ago). - Shift around ten years ago toward integrating multiple therapies. - Current and future emphasis on therapeutic synergy to improve patient outcomes. - Clinical observations suggest synergistic approaches yield better responses.
